Takeda Pharmaceuticals

Takeda Pharmaceuticals Boston, MA, USA
Job Title Job Description Objectives: Provides oversight from a clinical research and pharmacovigilance perspective of regulated post-authorization activities in the commercial business units and affiliates. Contributes to and implements the engagement strategy among R&D, Business Units and affiliates and Quality to ensure a global framework and robust quality systems are in place for the transition of R&D pipeline to the commercial space. Drives a fit-for-use global Quality framework that elevates the capabilities in the business units and the affiliate and enables them to deliver their clinical research and regulated activities with high compliance and agility. Establish and maintain relationships with key stakeholders outside R&D such as the commercial Business Units, affiliates. Global Medical, Commercial Quality, etc., supporting post-authorization strategies through thought partnership and linking R&D SMEs and experts, as needed. How will you...

Takeda Pharmaceuticals Washington, DC, USA
Job Description OBJECTIVES/PURPOSE: The Medical Communications Associate Director is a strategic partner of the US Medical Communications team responsible for supporting the development and execution of the medical communications strategy across the assigned therapeutic portfolio. Actively involved in the medical communications Scientific Communication Platform (SCP) and Integrated Communication Platform (ICP) development; content generation, which may include, but is not limited to, scientific slide decks, field medical tools, training materials, congress-related activities, websites/tools, and other medical programs. Supports execution of key medical communications tactics and activities, in an independent manner, closely coordinated with the Director US Medical Communications. The Medical Communications Associate Director is a member of the Scientific Communications Team reporting to the Director US Medical Communications for the assigned therapeutic area. SCOPE: This...